Tenax Therapeutics (TENX) Stock News
$TENX · NASDAQ · 1 stories in 30 daysBORSA has published 1 story on Tenax Therapeutics (TENX) in the past 30 days. BORSA’s news read on TENX is bearish at 36/100, +1 over 24 hours, based on 1 company event over the past 7 days. TENX last closed at $1.79 on Oct 30, up 4.07% over five sessions and down 7.25% over the past month. Tenax Therapeutics’ next earnings report is scheduled for Wednesday, Nov 11.
The wire on $TENX
newest first · updated · direct subject stories onlyBerger Montague announces a securities class action against Tenax Therapeutics (TENX) alleging the company overstated the prospects of its lead drug TNX-103. The Phase 3 LEVEL trial failed on August 10, 2026, triggering an 89.77% stock decline. Lead plaintiff deadline is December 28, 2026.
neutral 50 · impact 30The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
Tenax Therapeutics (TENX) stock: common questions
Is the news on TENX bullish or bearish?
BORSA’s news read on TENX is bearish at 36/100, +1 over 24 hours, based on 1 company event over the past 7 days. It measures the news only: it is separate from price action and is not investment advice.